Exploring the Use of Telemonitoring for Patients at High Risk for Hypertensive Disorders of Pregnancy in the Antepartum and Postpartum Periods: Scoping Review.

blood pressure eHealth high-risk pregnancy mHealth mobile phone preeclampsia smartphone telemedicine telemetry

Journal

JMIR mHealth and uHealth
ISSN: 2291-5222
Titre abrégé: JMIR Mhealth Uhealth
Pays: Canada
ID NLM: 101624439

Informations de publication

Date de publication:
17 04 2020
Historique:
received: 20 06 2019
accepted: 24 01 2020
revised: 15 10 2019
entrez: 18 4 2020
pubmed: 18 4 2020
medline: 7 4 2021
Statut: epublish

Résumé

High blood pressure complicates 2% to 8% of pregnancies, and its complications are present in the antepartum and postpartum periods. Blood pressure during and after pregnancy is routinely monitored during clinic visits. Some guidelines recommend using home blood pressure measurements for the management and treatment of hypertension, with increased frequency of monitoring for high-risk pregnancies. Blood pressure self-monitoring may have a role in identifying those in this high-risk group. Therefore, this high-risk pregnancy group may be well suited for telemonitoring interventions. The aim of this study was to explore the use of telemonitoring in patients at high risk for hypertensive disorders of pregnancy (HDP) during the antepartum and postpartum periods. This paper aims to answer the following question: What is the current knowledge base related to the use of telemonitoring interventions for the management of patients at high risk for HDP? A literature review following the methodological framework described by Arksey et al and Levac et al was conducted to analyze studies describing the telemonitoring of patients at high risk for HDP. A qualitative study, observational studies, and randomized controlled trials were included in this scoping review. Of the 3904 articles initially identified, 20 met the inclusion criteria. Most of the studies (13/20, 65%) were published between 2017 and 2018. In total, there were 16 unique interventions described in the 20 articles, all of which provide clinical decision support and 12 of which are also used to facilitate the self-management of HDP. Each intervention's design and process of implementation varied. Overall, telemonitoring interventions for the management of HDP were found to be feasible and convenient, and they were used to facilitate access to health services. Two unique studies reported significant findings for the telemonitoring group, namely, spontaneous deliveries were more likely, and one study, reported in two papers, described inductions as being less likely to occur compared with the control group. However, the small study sample sizes, nonrandomized groups, and short study durations limit the findings from the included articles. Although current evidence suggests that telemonitoring could provide benefits for managing patients at high risk for HDP, more research is needed to prove its safety and effectiveness. This review proposes four recommendations for future research: (1) the implementation of large prospective studies to establish the safety and effectiveness of telemonitoring interventions; (2) additional research to determine the context-specific requirements and patient suitability to enhance accessibility to healthcare services for remote regions and underserved populations; (3) the inclusion of privacy and security considerations for telemonitoring interventions to better comply with healthcare information regulations and guidelines; and (4) the implementation of studies to better understand the effective components of telemonitoring interventions.

Sections du résumé

BACKGROUND
High blood pressure complicates 2% to 8% of pregnancies, and its complications are present in the antepartum and postpartum periods. Blood pressure during and after pregnancy is routinely monitored during clinic visits. Some guidelines recommend using home blood pressure measurements for the management and treatment of hypertension, with increased frequency of monitoring for high-risk pregnancies. Blood pressure self-monitoring may have a role in identifying those in this high-risk group. Therefore, this high-risk pregnancy group may be well suited for telemonitoring interventions.
OBJECTIVE
The aim of this study was to explore the use of telemonitoring in patients at high risk for hypertensive disorders of pregnancy (HDP) during the antepartum and postpartum periods. This paper aims to answer the following question: What is the current knowledge base related to the use of telemonitoring interventions for the management of patients at high risk for HDP?
METHODS
A literature review following the methodological framework described by Arksey et al and Levac et al was conducted to analyze studies describing the telemonitoring of patients at high risk for HDP. A qualitative study, observational studies, and randomized controlled trials were included in this scoping review.
RESULTS
Of the 3904 articles initially identified, 20 met the inclusion criteria. Most of the studies (13/20, 65%) were published between 2017 and 2018. In total, there were 16 unique interventions described in the 20 articles, all of which provide clinical decision support and 12 of which are also used to facilitate the self-management of HDP. Each intervention's design and process of implementation varied. Overall, telemonitoring interventions for the management of HDP were found to be feasible and convenient, and they were used to facilitate access to health services. Two unique studies reported significant findings for the telemonitoring group, namely, spontaneous deliveries were more likely, and one study, reported in two papers, described inductions as being less likely to occur compared with the control group. However, the small study sample sizes, nonrandomized groups, and short study durations limit the findings from the included articles.
CONCLUSIONS
Although current evidence suggests that telemonitoring could provide benefits for managing patients at high risk for HDP, more research is needed to prove its safety and effectiveness. This review proposes four recommendations for future research: (1) the implementation of large prospective studies to establish the safety and effectiveness of telemonitoring interventions; (2) additional research to determine the context-specific requirements and patient suitability to enhance accessibility to healthcare services for remote regions and underserved populations; (3) the inclusion of privacy and security considerations for telemonitoring interventions to better comply with healthcare information regulations and guidelines; and (4) the implementation of studies to better understand the effective components of telemonitoring interventions.

Identifiants

pubmed: 32301744
pii: v8i4e15095
doi: 10.2196/15095
pmc: PMC7195666
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e15095

Subventions

Organisme : CIHR
Pays : Canada

Informations de copyright

©Maria Aquino, Sarah Munce, Janessa Griffith, Maureen Pakosh, Mikayla Munnery, Emily Seto. Originally published in JMIR mHealth and uHealth (http://mhealth.jmir.org), 17.04.2020.

Références

Eur J Obstet Gynecol Reprod Biol. 2018 Apr;223:72-78
pubmed: 29500948
Eur J Obstet Gynecol Reprod Biol. 2001 Nov;99(1):109-11
pubmed: 11604197
Bull World Health Organ. 2019 Jan 1;97(1):59-67
pubmed: 30618466
Int J Womens Health. 2010 Sep 30;2:327-37
pubmed: 21151680
Anadolu Kardiyol Derg. 2014 Dec;14(8):711-8
pubmed: 25188760
Hypertens Res. 2017 Jul;40(7):679-684
pubmed: 28179623
Am J Obstet Gynecol. 2002 Jun;186(6):1174-7
pubmed: 12066093
BMJ Qual Saf. 2018 Nov;27(11):871-877
pubmed: 29703800
Implement Sci. 2010 Sep 20;5:69
pubmed: 20854677
IEEE J Biomed Health Inform. 2014 Nov;18(6):1857-64
pubmed: 25375683
Reprod Health. 2016 Sep 30;13(Suppl 2):107
pubmed: 27719680
Int J Med Inform. 2008 Jul;77(7):470-6
pubmed: 17923433
Int J Gynaecol Obstet. 2003 Jul;82(1):89-103; discussion 87-8
pubmed: 12834953
Hypertens Pregnancy. 2012;31(1):131-9
pubmed: 21332327
Obstet Gynecol. 2005 Feb;105(2):402-10
pubmed: 15684172
Am J Obstet Gynecol. 2012 Jun;206(6):470-5
pubmed: 21963308
JAMA. 1988 Jan 8;259(2):225-8
pubmed: 3336140
Int J Biomed Comput. 1987 Nov;21(3-4):175-87
pubmed: 3679578
PLoS One. 2013 May 22;8(5):e64126
pubmed: 23717547
Semin Perinatol. 2012 Feb;36(1):56-9
pubmed: 22280867
Kaohsiung J Med Sci. 2018 Feb;34(2):109-112
pubmed: 29413226
Pregnancy Hypertens. 2016 Oct;6(4):263-265
pubmed: 27939464
Hypertension. 2018 Feb;71(2):326-335
pubmed: 29229741
BMC Pregnancy Childbirth. 2017 Dec 19;17(1):427
pubmed: 29258469
Telemed J E Health. 2017 Oct;23(10):833-841
pubmed: 28475431
Obstet Gynecol. 2013 Nov;122(5):1122-31
pubmed: 24150027
Ultrasound Obstet Gynecol. 2019 Apr;53(4):496-502
pubmed: 29516615
Blood Press Monit. 2018 Jun;23(3):171-174
pubmed: 29596069
Br J Obstet Gynaecol. 1992 Mar;99(3):182-5
pubmed: 1606113
JMIR Mhealth Uhealth. 2018 May 30;6(5):e130
pubmed: 29848473
J Med Internet Res. 2018 Jun 05;20(6):e202
pubmed: 29871855
Hypertens Res. 2014 Jun;37(6):543-7
pubmed: 24572912
Ultrasound Obstet Gynecol. 2018 Apr;51(4):524-530
pubmed: 29468771
JMIR Mhealth Uhealth. 2017 Mar 09;5(3):e25
pubmed: 28279948
Semin Perinatol. 2009 Jun;33(3):130-7
pubmed: 19464502
J Hypertens. 1998 Jul;16(7):971-5
pubmed: 9794737
Hypertension. 2018 Sep;72(3):686-694
pubmed: 30354754
Am J Obstet Gynecol. 2009 May;200(5):481.e1-7
pubmed: 19019323
J Perinatol. 1998 May-Jun;18(3):226-9
pubmed: 9659655
Telemed J E Health. 2005 Feb;11(1):63-9
pubmed: 15785222
J Am Acad Nurse Pract. 2003 Aug;15(8):371-5
pubmed: 14509102
Hypertension. 2008 Jul;52(1):1-9
pubmed: 18497371
Health Promot Pract. 2018 May;19(3):331-340
pubmed: 28578606
Diabetes Technol Ther. 2012 Jul;14(7):624-9
pubmed: 22512287
Afr J Reprod Health. 2013 Mar;17(1):41-8
pubmed: 24069733
J Med Internet Res. 2018 Mar 26;20(3):e102
pubmed: 29581094
Syst Rev. 2016 Dec 5;5(1):210
pubmed: 27919275
Eur J Obstet Gynecol Reprod Biol. 1997 Dec;75(2):147-53
pubmed: 9447367
Hypertens Pregnancy. 2008;27(3):305-13
pubmed: 18696359
Curr Diab Rep. 2015 Dec;15(12):109
pubmed: 26458380
Hypertension. 2018 Aug;72(2):425-432
pubmed: 29967037
J Med Internet Res. 2017 Sep 27;19(9):e327
pubmed: 28954715
J Prenat Med. 2009 Jan;3(1):1-5
pubmed: 22439030
Pregnancy Hypertens. 2018 Apr;12:161-168
pubmed: 29242046
Healthc Financ Manage. 2005 Apr;59(4):46-8, 50, 52
pubmed: 15853034
PLoS One. 2018 Jul 18;13(7):e0199883
pubmed: 30020958
Can J Cardiol. 2018 May;34(5):526-531
pubmed: 29731014
Reprod Health. 2018 Jul 4;15(1):120
pubmed: 29973229
Diabetes Res Clin Pract. 2010 Feb;87(2):e15-7
pubmed: 20044162
BMJ. 2014 Nov 18;349:g6616
pubmed: 25406132
Hypertens Res. 2013 Aug;36(8):661-72
pubmed: 23595050
Pregnancy Hypertens. 2016 Oct;6(4):406-412
pubmed: 27939491
BMC Pregnancy Childbirth. 2017 Dec 28;17(1):442
pubmed: 29284456

Auteurs

Maria Aquino (M)

Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Centre for Global eHealth Innovation, Techna Institute, University Health Network, Toronto, ON, Canada.

Sarah Munce (S)

Rumsey Centre, Toronto Rehabilitation Institute, University Health Network, Toronto, ON, Canada.

Janessa Griffith (J)

Institute of Medical Science, University of Toronto, Toronto, ON, Canada.
Women's College Hospital Institute for Health System Solutions and Virtual Care, Women's College Hospital, Toronto, ON, Canada.

Maureen Pakosh (M)

Library & Information Services, Toronto Rehabilitation Institute, University Health Network, Toronto, ON, Canada.

Mikayla Munnery (M)

Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.

Emily Seto (E)

Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Centre for Global eHealth Innovation, Techna Institute, University Health Network, Toronto, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH